Introduction: The purpose of this study was to investigate the safety and efficacy of transcorneal electrical stimulation (TES) in patients suffering from retinal artery occlusion (RAO).
Methods: Twelve patients with central and one patient with branch RAO (age 25-84 years, median 74 years) were enrolled in this prospective, randomized, sham-controlled study. RAO was diagnosed 10 days to 17 months prior to study participation. Patients were treated with TES (5 ms positive followed by 5 ms negative biphasic pulses at 20 Hz; applied with DTL electrodes) for 30 min once a week for 6 consecutive weeks. Patients were randomly assigned to TES with 0 mA (sham, n = 3), 66% (n = 5) or 150% (n = 5) of the patient's individual electrical phosphene threshold (EPT) at 20 Hz. Best corrected visual acuity, ophthalmology examination and EPT (at 3, 6, 9, 20, 40, 60, and 80 Hz) were determined at baseline and at eight follow-up visits over 17 weeks. During four visits (week 1, 5, 9, and 17) kinetic and static visual fields as well as full-field and multifocal electroretinography were measured. The method of restricted maximum likelihood (P < 0.05, Tukey-Kramer) was used to estimate the development of parameters under treatment.
Results: TES was tolerated well; no ocular or systemic adverse events were observed except for foreign-body sensation after TES (n = 3). During the study period the slopes of the scotopic a-wave increased significantly (high-intensity flash white 10 cd.s/m(2); P = 0.03) in the 150% treatment group. All other parameters in all other groups remained statistically unchanged.
Conclusions: Although TES was tolerated well, statistically significant improvements were found only for specific a-wave slopes. This is in contradiction to previous smaller, uncontrolled reports. Further studies with larger sample sizes and longer duration might, however, show additional significant effects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108151 | PMC |
| http://dx.doi.org/10.1007/s40123-013-0012-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Seizures elicited by transcorneal 6 Hz stimulation in developing rats.
PLoS One
January 2025
Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Seizures elicited by corneal 6-Hz stimulation are widely acknowledged as a model of temporal lobe seizures. Despite the intensive research in rodents, no studies hint at this model in developing animals. We focused on seven age groups of both male and female rats.
View Article and Find Full Text PDFTranscorneal electrical stimulation restores DNA methylation changes in retinal degeneration.
Front Mol Neurosci
December 2024
Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Background: Retinal degeneration is a major cause of irreversible blindness. Stimulation with controlled low-level electrical fields, such as transcorneal electrical stimulation (TES), has recently been postulated as a therapeutic strategy. With promising results, there is a need for detailed molecular characterization of the therapeutic effects of TES.
View Article and Find Full Text PDFBrivaracetam and rufinamide combination increased seizure threshold and improved neurobehavioral deficits in corneal kindling model of epilepsy.
Animal Model Exp Med
October 2024
Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Background: Besides seizures, a myriad of overlapping neuropsychiatric and cognitive comorbidities occur in patients with epilepsy, which further debilitates their quality of life. This study provides an in-depth characterization of the impact of brivaracetam and rufinamide individually and in combination at 10 and 20 mg/kg doses, respectively, on corneal kindling-induced generalized seizures and behavioral alterations. Furthermore, observed convulsive frequency and behavioral changes were correlated to post-kindling-induced changes in the activity of markers of oxidative stress.
View Article and Find Full Text PDFChronic electrical stimulation with a peripheral suprachoroidal retinal implant: a preclinical safety study of neuroprotective stimulation.
Front Cell Dev Biol
June 2024
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
Article Synopsis
- Extraocular electrical stimulation can protect retinal cells but currently relies on patients frequently setting up external electrodes, which is inconvenient.
- A new minimally-invasive implant has been developed to provide a reliable method for chronic electrical stimulation of the retina, aimed at improving patient adherence to treatment.
- In a study with adult felines, the device showed surgical and stimulation safety with no adverse effects, stable electrode performance, and no significant changes to retinal health, suggesting it could be a viable long-term solution.
Article Synopsis
- - This study explores transcorneal electrical stimulation (TES) as a method to protect photoreceptors in the retina against degeneration by inducing electric fields, which has not been thoroughly examined in living organisms.
- - Researchers created a computational model of a rat's head to simulate the electric fields and then validated it through experiments on Royal College of Surgeon (RCS) rats, finding specific stimulation amplitudes necessary to achieve effective current density levels for neuroprotection.
- - The results indicate that the computational modeling developed in this research can help optimize electrode designs and stimulation parameters, providing a cost-effective way to improve future studies on TES without needing extensive live testing.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!